Materna Medical is a pioneering company in the field of women's health, specifically focusing on addressing pelvic health issues with innovative medical devices. Founded in 2010 by Mark Juravic and Michael Stewart, the company is based in Mountain View, California. Materna Medical has developed products aimed at reducing pelvic floor injuries during childbirth and treating conditions like vaginismus. As of May 2024, Materna Medical has raised $57.6 million in funding, with investments from firms such as InnovaHealth Partners.
| Attribute | Information |
|---|---|
| Founding Date | 2010 |
| Headquarters | Mountain View, California, USA |
| Founders | Mark Juravic, Michael Stewart |
| Revenue | Not publicly disclosed |
| Profits | Not publicly disclosed |
| Key Investors | InnovaHealth Partners, Wavemaker 360 Health |
| Industry | Medical Devices, Women's Health |
| Number of Employees | Approximately 10 |
Materna Medical began its journey in 2010 with a mission to address significant, unmet needs in women's pelvic health. The company was founded by Mark Juravic and Michael Stewart, driven by the understanding that a large portion of women experience pelvic conditions post childbirth or due to medical issues like vaginismus. In its early days, the company focused on research and development, aiming to create devices that prevent common injuries during childbirth and effectively treat conditions that were often misunderstood and misdiagnosed. Their first significant product, the Milli Vaginal Dilator, launched with a design tailored to widen options for women managing pelvic discomfort.
As a leader in the femtech industry, Materna Medical has made strides with its comprehensive approach to women's pelvic health. The company’s flagship product, the Milli Vaginal Dilator, was launched in 2019 as a consumer wellness product. This dilator is marketed for treating vaginismus and managing pelvic pain, conditions that can significantly impact women's quality of life.
Materna Medical currently operates within the $6 billion market addressing pelvic health conditions. The company is recognized for its cutting-edge medical devices that assist in the prevention and treatment of pelvic floor injuries. Its devices are being studied in pivotal trials across major hospital systems, indicating strong market trust and a potential shift in standard care practices. Materna Medical’s products aim to reduce healthcare costs by preventing long-term complications associated with untreated pelvic conditions. The company’s competitive edge lies in its innovative approach, comprehensive product design, and strong backing from reputable investors, which collectively position it well in the expanding femtech space.
Materna Medical stands out in the medical technology landscape due to its dedicated focus on women's pelvic health, an often neglected area. With its innovative products, significant funding, and rigorous clinical trials, the company is well-positioned to make lasting impacts in women's health care. As Materna continues to advance its technologies and expand its market reach, it is poised to contribute significantly to improving the quality of life for women, potentially setting new standards in the treatment and prevention of pelvic health issues. Looking ahead, Materna Medical may lead a broader adoption of advanced pelvic health solutions, influencing healthcare practices globally.